Condition: Refractory Metastatic Colorectal Cancer · Sponsor: Delcath Systems Inc.
The goal of this clinical trial is to learn if using a liver-directed therapy with high dose chemotherapy followed by approved cancer treatment to treat patients with colorectal cancer that has spread to the liver is safe and tolerable. The clinical trial will also learn if the liver-directed therapy with high dose chemotherapy works on the disease in the liver. Investigators will compare the use of the liver-directed therapy with high dose chemotherapy followed by approved cancer treatment or approved cancer treatment alone. Participants will: * Undergo up to two liver-directed therapy with high dose chemotherapy procedures followed by approved cancer treatment or take approved cancer treatment alone * Visit clinic at least every two weeks for checkups and tests * Complete scans approximately every two months
This description comes directly from the study's public registry record.
Matthew Cooney, MD · 216-374-8221 · MedicalMonitoring@delcath.com
Always discuss trial participation with your own doctor first.
| City of Hope | Duarte, California, United States | Recruiting |
| UCLA Hematology/Oncology-Santa Monica | Santa Monica, California, United States | Recruiting |
| Moffitt Cancer Center | Tampa, Florida, United States | Recruiting |
| The University of Kansas Clinical Research Center | Fairway, Kansas, United States | Recruiting |
| Ochsner Clinic Foundation | New Orleans, Louisiana, United States | Recruiting |
| Huntsman Cancer Institute, University of Utah | Salt Lake City, Utah, United States | Recruiting |
| Czech Republic - University Hospital | Prague, Czechia | Recruiting |
| Medizinische Hochschule Hannover | Hanover, Germany | Recruiting |
| Helios Park-Klinikum Leipzig | Leipzig, Germany | Recruiting |
| Instiuto Europeo de Oncologia | Milan, Italy | Recruiting |
| Leiden University Medical Center (LUMC) | Leiden, Netherlands | Recruiting |
| Clinical Hospital Center "Bezanijska Kosa" | Belgrade, Serbia | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06607458